No difference in clinical parameters and drug retention in PsA patients receiving b/tsDMARD monotherapy versus combination with methotrexate: data from the RABBIT-SpA registry

Background The potential benefit of methotrexate (MTX) in combination with biologic (b) and targeted synthetic (ts) disease modifying anti-rheumatic drugs (DMARDs) in psoriatic arthritis (PsA) is still a matter of debate.Objectives To compare clinical and patient reported characteristics as well as...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Philipp Sewerin, Georg Schett, Anja Strangfeld, David Kiefer, Anja Weiß, Andreas Krause, Anne Constanze Regierer
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMJ Publishing Group 2024-09-01
Edice:	RMD Open
On-line přístup:	https://rmdopen.bmj.com/content/10/3/e004389.full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!